Evidence for a sulfo-conjugate as active metabolite of cicletanine
Garay, R.P.; Rosati, C.; Nazaret, C.; Esanu, A.; Berthet, P.; Tarrade, T.; Braquet, P.
Journal of Hypertension. Supplement Official Journal of the International Society of Hypertension 9(6): S342-S343
1991
ISSN/ISBN: 0952-1178 PMID: 1818992 Document Number: 376079
Document emailed within 1 workday
Related Documents
Ding, J-Jie.; Jiao, Z.; Yu, Y-Qiu.; Shi, X-Jin. 2007: Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone Yao Xue Xue Bao 42(6): 631-638May, D.G.; Naukam, R.J.; Kambam, J.R.; Branch, R.A. 1992: Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl Journal of Pharmacology and Experimental Therapeutics 262(3): 1057-1061
Ishizuka, T.; Komiya, I.; Hiratsuka, A.; Watabe, T. 1990: Novel type of ornithine-glutathione double conjugate excreted as a major metabolite into the bile of rats administered clebopride Molecular Pharmacology 37(6): 983-989
Lavelle, F.; Bissery, M.C.; André, S.; Roquet, F.; Riou, J.F. 1996: Preclinical evaluation of CPT-11 and its active metabolite SN-38 Seminars in Oncology 23(1 Suppl 3: 11-20
Grodzinska, L.; Basista, M.; Koenig, E. 1987: Antithrombotic properties of the active metabolite of molsidomine, SIN-1 Pathologie-Biologie 35(2 Part 2): 233-234
Lapka, R.; Brejcha, A.; Smolík, S.; Franc, Z. 1990: Disposition of [3H]flobufen and its active metabolite in rats Ceskoslovenska Farmacie 39(10): 443-447
Klöcking, H.P.; Hoffmann, A.; Markwardt, F. 1987: Release of plasminogen activator by molsidomine and its active metabolite SIN-1 Die Pharmazie 42(5): 354
Nattel, S. 1986: Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite Journal of Cardiovascular Pharmacology 8(4): 771-777
Waud, W.R.; Tiwari, A.; Schmid, S.M.; Shih, T.W.; Strong, J.M.; Hartman, N.R.; O'Reilly, S.; Struck, R.F. 1997: 4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine Cancer Research 57(5): 815-817
Hutson, D.H.; Logan, C.J.; Regan, P.D. 1984: Evidence for the formation of a novel glutathione conjugate in the metabolism of an aromatic amine derivative Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(4): 523-524
Zhong, D.; Blume, H. 1994: HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma Die Pharmazie 49(1): 38-41
Zhao, L-mei.; Chen, X-yan.; Cui, J-jun.; Sunita, M.; Zhong, D-fang. 2004: Determination of tramadol and its active metabolite O-desmethyltramadol in plasma and amniotic fluid using LC/MS/MS Yao Xue Xue Bao 39(6): 458-462
Gao, L.-C.; Huang, X.; Tan, Z.-R.; Fan, L.; Zhou, H.-H. 2012: The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men European Review for Medical and Pharmacological Sciences 16(9): 1192-1196
Kim, C-Seong.; Choi, S-Jun.; Park, C-Young.; Li, C.; Choi, J-Shik. 2010: Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats Anticancer Research 30(1): 79-85
Choi, J.S.; Choi, J.S.; Choi, D.H. 2013: Effects of licochalcon a on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats Die Pharmazie 68(11): 882-888
Yamaguchi, T.; Hashizume, T.; Matsuda, M.; Sakashita, M.; Fujii, T.; Sekine, Y.; Nakashima, M.; Uematsu, T. 1994: Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects Arzneimittel-Forschung 44(1): 59-64
Tabata, S.; Yamazaki, H.; Ohtake, Y.; Hayashi, S. 1990: Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats Arzneimittel-Forschung 40(8): 865-867
Vella, P.P.; Staub, J.M.; Armstrong, J.; Dolan, K.T.; Rusk, C.M.; Szymanski, S.; Greer, W.E.; Marburg, S.; Kniskern, P.J.; Schofield, T.L. 1990: Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB) Pediatrics 85(4 Part 2): 668-675
Kolassa, N.; Schützenberger, W.G.; Wiener, H.; Krivanek, P. 1979: Plasma level of the prodrug midodrine and its active metabolite in comparison with the alpha-mimetic action in dogs Archives Internationales de Pharmacodynamie et de Therapie 238(1): 96-104
Sladek, N.E. 1973: Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide Cancer Research 33(4): 651-658